TerrAscend (TSNDF) Assets Average (2022 - 2026)
TerrAscend's (TSNDF) quarterly Assets Average came in at $553.2 million in Q1 2026, down 8.4% year-on-year from $604.0 million in Q1 2025, and down 0.55% on a QoQ basis from $556.3 million in Q4 2025.
TerrAscend (TSNDF) Assets Average (2022 - 2026) Analysis & Trends
TerrAscend (TSNDF) has 5 years of Assets Average data on file, last reported at $553.2 million in Q1 2026.
- On a quarterly basis, Assets Average fell 8.4% year-over-year to $553.2 million in Q1 2026; TTM through Mar 2026 was $553.2 million, a 8.4% decrease from a year earlier, with the FY2025 full-year figure at $582.3 million, down 8.57% from the prior year.
- Assets Average for Q1 2026 stood at $553.2 million, down from $556.3 million in the prior quarter.
- Over the last five years, Assets Average for TSNDF reached as high as $1.0 billion in Q2 2022 and fell as low as $350.8 million in Q2 2023.
- Historically, Assets Average has averaged $647.4 million across 5 years, with a median of $657.9 million in 2024.
- Across the five-year window, Assets Average slumped 65.69% in 2023 and soared 87.52% in 2024, its largest moves.
- Year by year, Assets Average stood at $713.5 million in 2022, then decreased by 1.81% to $700.6 million in 2023, then slipped by 9.78% to $632.1 million in 2024, then dropped by 11.99% to $556.3 million in 2025, then dropped by 0.55% to $553.2 million in 2026.
- Per Business Quant data, the three most recent Assets Average figures were $553.2 million in Q1 2026, $556.3 million in Q4 2025, and $563.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 40.39 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 15.32 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 99.52 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 7.30 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 68.63 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 37.01 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 4.77 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 13.29 Bn |
| 10 | TerrAscend | 160.44 Mn | 162.98 Mn | 34.60 Mn | 553.24 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 553.24 Mn |
| Dec 31, 2025 | 556.32 Mn |
| Sep 30, 2025 | 563.63 Mn |
| Jun 30, 2025 | 586.37 Mn |
| Mar 31, 2025 | 603.98 Mn |
| Dec 31, 2024 | 632.08 Mn |
| Sep 30, 2024 | 658.59 Mn |
| Jun 30, 2024 | 657.89 Mn |
| Mar 31, 2024 | 661.03 Mn |
| Dec 31, 2023 | 700.59 Mn |
| Sep 30, 2023 | 367.38 Mn |
| Jun 30, 2023 | 350.83 Mn |
| Mar 31, 2023 | 701.58 Mn |
| Dec 31, 2022 | 713.54 Mn |
| Sep 30, 2022 | 867.05 Mn |
| Jun 30, 2022 | 1.02 Bn |
| Mar 31, 2022 | 809.17 Mn |